Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 39201000168116 | Optiray-320 Ultraject (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 39211000168118 | Optiray-320 Ultraject | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optiray-320 Ultraject | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe | Is a | True | Optiray-320 Ultraject | Inferred relationship | Some | |
| Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 10 x 75 mL syringes | has TP | True | Optiray-320 Ultraject | Inferred relationship | Some | |
| Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 20 x 75 mL syringes | has TP | True | Optiray-320 Ultraject | Inferred relationship | Some | |
| Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 20 x 75 mL syringes | has TP | True | Optiray-320 Ultraject | Inferred relationship | Some | |
| Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 10 x 75 mL syringes | has TP | True | Optiray-320 Ultraject | Inferred relationship | Some |
Reference Sets
FHIR